SANDRA PELAEZ-MUNSEY: Open Payments
NPI 1942747126 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,068 in 93 payments from 13 companies in 2025. Trend: 2023 $3,029 · 2024 $11,492 · 2025 $2,068
Food & beverage: $2,068
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $391 |
| ABBVIE INC. | 20 | $272 |
| Lundbeck LLC | 13 | $268 |
| E.R. Squibb & Sons, L.L.C. | 5 | $236 |
| Axsome Therapeutics, Inc. | 11 | $216 |
| Almatica Pharma LLC | 7 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $131 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $89 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| Tris Pharma Inc | 3 | $69 |
Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, LOREEV XR, ABILIFY MAINTENA, CAPLYTA, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
